Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Preferred Stock Liabilities (2022)

Historic Preferred Stock Liabilities for CervoMed (CRVO) over the last 1 years, with Q4 2022 value amounting to $24.3 million.

  • CervoMed's Preferred Stock Liabilities changed N/A to $24.3 million in Q4 2022 from the same period last year, while for Dec 2022 it was $24.3 million, marking a year-over-year change of. This contributed to the annual value of $24.3 million for FY2022, which is N/A changed from last year.
  • As of Q4 2022, CervoMed's Preferred Stock Liabilities stood at $24.3 million.
  • Over the past 5 years, CervoMed's Preferred Stock Liabilities peaked at $24.3 million during Q4 2022, and registered a low of $24.3 million during Q4 2022.